Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 67

1.

Causes of progressive cerebellar ataxia: prospective evaluation of 1500 patients.

Hadjivassiliou M, Martindale J, Shanmugarajah P, Grünewald RA, Sarrigiannis PG, Beauchamp N, Garrard K, Warburton R, Sanders DS, Friend D, Duty S, Taylor J, Hoggard N.

J Neurol Neurosurg Psychiatry. 2017 Apr;88(4):301-309. doi: 10.1136/jnnp-2016-314863. Epub 2016 Dec 13.

PMID:
27965395
2.

Is Cognitive Test-Taking Anxiety Associated With Academic Performance Among Nursing Students?

Duty SM, Christian L, Loftus J, Zappi V.

Nurse Educ. 2016 Mar-Apr;41(2):70-4. doi: 10.1097/NNE.0000000000000208.

PMID:
26312822
3.

Laundering habits of student nurses and correlation with the presence of Staphylococcus aureus on nursing scrub tops pre- and postlaundering.

Scott E, Goodyear N, Nicoloro JM, Marika DJ, Killion E, Duty SM.

Am J Infect Control. 2015 Sep 1;43(9):1006-8. doi: 10.1016/j.ajic.2015.05.007. Epub 2015 Jul 2.

PMID:
26143576
4.

Brain morphometry and the neurobiology of levodopa-induced dyskinesias: current knowledge and future potential for translational pre-clinical neuroimaging studies.

Finlay CJ, Duty S, Vernon AC.

Front Neurol. 2014 Jun 12;5:95. doi: 10.3389/fneur.2014.00095. eCollection 2014. Review.

5.

Therapeutic potential of targeting glutamate receptors in Parkinson's disease.

Finlay C, Duty S.

J Neural Transm (Vienna). 2014 Aug;121(8):861-80. doi: 10.1007/s00702-014-1176-4. Epub 2014 Feb 21. Review.

PMID:
24557498
6.

The use of haematopoietic stem cell transplantation in Fanconi anaemia patients: a survey of decision making among families in the US and Canada.

Hutson SP, Han PK, Hamilton JG, Rife SC, Al-Rahawan MM, Moser RP, Duty SP, Anand S, Alter BP.

Health Expect. 2015 Oct;18(5):929-41. doi: 10.1111/hex.12066. Epub 2013 Apr 29.

7.

Improving satisfaction with care and reducing length of stay in an obstetric triage unit using a nurse-midwife-managed model of care.

Paul J, Jordan R, Duty S, Engstrom JL.

J Midwifery Womens Health. 2013 Mar-Apr;58(2):175-81. doi: 10.1111/j.1542-2011.2012.00239.x. Epub 2013 Mar 13.

PMID:
23489525
8.

Potential sources of bisphenol A in the neonatal intensive care unit.

Duty SM, Mendonca K, Hauser R, Calafat AM, Ye X, Meeker JD, Ackerman R, Cullinane J, Faller J, Ringer S.

Pediatrics. 2013 Mar;131(3):483-9. doi: 10.1542/peds.2012-1380. Epub 2013 Feb 18.

9.

Bisphenol A concentrations in maternal breast milk and infant urine.

Mendonca K, Hauser R, Calafat AM, Arbuckle TE, Duty SM.

Int Arch Occup Environ Health. 2014 Jan;87(1):13-20. doi: 10.1007/s00420-012-0834-9. Epub 2012 Dec 5.

10.
11.

Fibroblast growth factor-20 protects against dopamine neuron loss in vitro and provides functional protection in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.

Sleeman IJ, Boshoff EL, Duty S.

Neuropharmacology. 2012 Dec;63(7):1268-77. doi: 10.1016/j.neuropharm.2012.07.029. Epub 2012 Aug 10.

PMID:
22971544
12.

Riluzole neuroprotection in a Parkinson's disease model involves suppression of reactive astrocytosis but not GLT-1 regulation.

Carbone M, Duty S, Rattray M.

BMC Neurosci. 2012 Apr 5;13:38. doi: 10.1186/1471-2202-13-38.

13.

Allosteric modulation of the group III mGlu4 receptor provides functional neuroprotection in the 6-hydroxydopamine rat model of Parkinson's disease.

Betts MJ, O'Neill MJ, Duty S.

Br J Pharmacol. 2012 Aug;166(8):2317-30. doi: 10.1111/j.1476-5381.2012.01943.x.

14.

Riluzole elevates GLT-1 activity and levels in striatal astrocytes.

Carbone M, Duty S, Rattray M.

Neurochem Int. 2012 Jan;60(1):31-8. doi: 10.1016/j.neuint.2011.10.017. Epub 2011 Nov 6.

15.

Antiparkinsonian potential of targeting group III metabotropic glutamate receptor subtypes in the rodent substantia nigra pars reticulata.

Broadstock M, Austin PJ, Betts MJ, Duty S.

Br J Pharmacol. 2012 Feb;165(4b):1034-45. doi: 10.1111/j.1476-5381.2011.01515.x.

16.

Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease.

Duty S, Jenner P.

Br J Pharmacol. 2011 Oct;164(4):1357-91. doi: 10.1111/j.1476-5381.2011.01426.x. Review.

17.

Educating ethnic minority students for the nursing workforce: facilitators and barriers to success.

Loftus J, Duty S.

J Natl Black Nurses Assoc. 2010 Jul;21(1):7-16.

PMID:
20857771
18.

Therapeutic potential of targeting group III metabotropic glutamate receptors in the treatment of Parkinson's disease.

Duty S.

Br J Pharmacol. 2010 Sep;161(2):271-87. doi: 10.1111/j.1476-5381.2010.00882.x. Review.

19.

Symptomatic and neuroprotective effects following activation of nigral group III metabotropic glutamate receptors in rodent models of Parkinson's disease.

Austin PJ, Betts MJ, Broadstock M, O'Neill MJ, Mitchell SN, Duty S.

Br J Pharmacol. 2010 Aug;160(7):1741-53. doi: 10.1111/j.1476-5381.2010.00820.x.

20.

A critical evaluation of methicillin-resistant Staphylococcus aureus and other bacteria of medical interest on commonly touched household surfaces in relation to household demographics.

Scott E, Duty S, McCue K.

Am J Infect Control. 2009 Aug;37(6):447-53. doi: 10.1016/j.ajic.2008.12.001. Epub 2009 Apr 9.

PMID:
19361887

Supplemental Content

Support Center